MaxCyte Inc (GB:MXCT)
LSE:MXCT
Holding GB:MXCT?
Track your performance easily

MaxCyte (MXCT) Financial Statements

9 Followers

MaxCyte Financial Overview

MaxCyte's market cap is currently ―. The company's EPS TTM is p-0.27; its P/E ratio is -11.98; MaxCyte is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is p-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 10.43M$ 11.34M$ 15.66M$ 8.00M$ 9.04M
Gross Profit$ 8.94M$ 9.94M$ 14.09M$ 7.21M$ 7.67M
EBIT$ -9.38M$ -12.28M$ -8.10M$ -11.25M$ -10.51M
EBITDA$ -6.19M$ -11.16M$ -6.99M$ -11.65M$ -11.40M
Net Income Common Stockholders$ -9.38M$ -9.53M$ -5.28M$ -11.25M$ -10.51M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 157.33M$ 157.51M$ 168.29M$ 190.24M$ 216.11M
Total Assets$ 251.50M$ 257.93M$ 268.27M$ 266.73M$ 271.20M
Total Debt$ 18.53M$ 18.64M$ 18.74M$ 16.08M$ 16.21M
Net Debt$ -138.80M$ -138.87M$ -149.54M$ -174.16M$ -199.90M
Total Liabilities$ 30.23M$ 31.57M$ 36.11M$ 33.35M$ 30.22M
Stockholders Equity$ 221.26M$ 226.36M$ 232.17M$ 233.38M$ 240.98M
Cash Flow-
Free Cash Flow$ -5.13M$ -11.37M$ 66.80K$ -8.96M$ -10.61M
Operating Cash Flow$ -4.83M$ -10.56M$ 981.70K$ -8.24M$ -10.10M
Investing Cash Flow$ 19.39M$ -14.40M$ -4.14M$ 2.81M$ 26.67M
Financing Cash Flow$ 713.00K$ 703.00K$ 493.00K$ 36.70K$ 156.70K
Currency in USD

MaxCyte Earnings and Revenue History

MaxCyte Debt to Assets

MaxCyte Cash Flow

MaxCyte Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis